← Back to home

Patients with HER2-positive breast cancer (BC) suitable for neoadjuvant therapy

Clinical trials for Patients with HER2-positive breast cancer (BC) suitable for neoadjuvant therapy explained in plain language.

Never miss a new study

Get alerted when new Patients with HER2-positive breast cancer (BC) suitable for neoadjuvant therapy trials appear

Sign up with your email to follow new studies for Patients with HER2-positive breast cancer (BC) suitable for neoadjuvant therapy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Smart chemo: tailoring treatment for HER2+ breast cancer to reduce side effects

Disease control Not yet recruiting

This phase III trial tests a personalized approach for HER2-positive breast cancer, where treatment is adjusted based on early response (ctDNA and imaging). The goal is to reduce chemotherapy side effects without compromising effectiveness. The study will enroll 2000 women with e…

Matched conditions: PATIENTS WITH HER2-POSITIVE BREAST CANCER (BC) SUITABLE FOR NEOADJUVANT THERAPY

Phase 3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control

Last updated Jun 27, 2026 07:59 UTC

Patients with HER2-positive breast cancer (BC) suitable for neoadjuvant therapy

Get alerted when new Patients with HER2-positive breast cancer (BC) suitable for neoadjuvant therapy trials appear

Smart chemo: tailoring treatment for HER2+ breast cancer to reduce side effects